MetaCap

Omada Health Inc. (OMDA)

NASDAQ: OMDAHealth CareMedical/Nursing ServicesUSD

11.87-0.63 (-5.04%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

OMDA stock chart

Technical analysis

Key statistics

All statistics
Market cap
$736.39M
52-week range
10.28 – 25.45
Day range
11.76 – 12.64
Volume / Avg
1.71M / 1.33M
Beta
—

52-week range

$10.28$25.45

OMDA stock today

Shares of Omada Health (OMDA) finished lower on Nov 20 at $11.87, a drop of 5.04% or $0.63 per share, versus the S&P 500's 3.70% decline. Shares are 53.4% below their 52-week high of $25.45, set on Aug 27, 2026 and 15.5% above the 52-week low of $10.28, near the bottom of the past year's range. OMDA is down 24.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 36.2%.

At 29.7x trailing earnings, Omada Health trades below the peer-group median of 47.6x. Its forward P/E of 17.2x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Omada Health

Company profile

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care.

Industry
Medical/Nursing Services
CEO
Mr. Sean P. Duffy
Headquarters
South San Francisco, CA
Employees
980
IPO year
2025

Financial highlights

Full financials

In fiscal 2025, Omada Health generated $260.2 million in revenue, up 53.2% from fiscal 2024, its 2nd consecutive year of revenue growth. Omada Health reported a net loss of $12.8 million, compared with a loss of $47.1 million a year earlier. Gross margin was 65.7% (up from 60.6%) and operating margin -4.6%.

Omada Health annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023
Revenue$260.21M$169.80M$122.78M
Growth+53.24%+38.29%—
Net income$-12.78M$-47.14M$-67.51M
EPS (diluted)$-0.35$-6.11$-9.52

Analyst forecast

Forecast

Consensus (12 analysts)

buy

Avg. price target

$26.50+123.25%

  • Strong buy 5
  • Buy 5
  • Hold 2
  • Sell 0
  • Strong sell 0

Target range

Low $19.00High $35.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 5, 2026
EPS actual vs est.
$-0.03 vs $0.02
Surprise
-250.00%

OMDA news

All OMDA news

Omada Health peers

Health Care sector
OMDA peer companies
CompanyPrice% ChgMarket capCompare
SBCSBC Medical Group Holdings Incorporated5.17-7.68%$530.32Mvs OMDA
AHCOAdaptHealth Corp.7.20-0.69%$982.98Mvs OMDA
SRTAStrata Critical Medical Inc. Class A4.56-5.59%$407.30Mvs OMDA
PIIIP3 Health Partners Inc. Class A1.69-9.14%$350.24Mvs OMDA
STLNStarling Oncology Inc.3.00-5.66%$305.97Mvs OMDA
AUNAAuna SA Class A3.66-6.15%$271.05Mvs OMDA
PNTGThe Pennant Group Inc.34.64+1.61%$1.22Bvs OMDA
INNVInnovAge Holding Corp.9.16+2.81%$1.25Bvs OMDA

Indexes, lists and sector

Omada Health stock FAQ

What is Omada Health's stock price today?

OMDA last traded at $11.87 as of Nov 20, 4:00 PM EST, down 5.04% on the day. Prices are delayed at least 15 minutes.

What is OMDA's P/E ratio?

OMDA trades at a trailing P/E ratio of 29.68 and a forward P/E of 17.18, compared with a median of 47.6 for its closest peers.

Who is Omada Health's CEO?

Mr. Sean P. Duffy is the chief executive officer of Omada Health Inc., which has about 980 employees.

What is the OMDA 52-week high?

The 52-week high for OMDA is $25.45 and the 52-week low is $10.28. The stock is currently 53.4% below its high.

Compare OMDA